Apelin-36 vs Relaxin-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-36 is the full-length 36-amino acid form of the apelin peptide family, encoded by the APLN gene. It activates the APJ (APLNR) receptor, a Gi-coupled GPCR, producing cardiovascular effects including vasodilation, positive inotropy, and cardioprotection. The largest naturall...
Calculate Apelin-36 dose →Relaxin-2 (H2 Relaxin) is an endogenous peptide hormone of the insulin superfamily, best known for its roles in pregnancy physiology including cervical ripening, uterine quiescence, and connective tissue remodeling. Beyond reproduction, relaxin-2 is a systemic anti-fibrotic and v...
Calculate Relaxin-2 dose →| Parameter | Apelin-36 | Relaxin-2 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical / Phase 2 | Clinical |
| Half-Life | 2-5 minutes (IV) | 10-15 min (plasma) |
| Typical Dose | 1-10 nmol/kg IV (research) | 30-300 mcg/kg/day (IV) |
| Frequency | Variable | Continuous 48-hour infusion (trials) |
| Route | IV / SC (research) | Intravenous (infusion) |
| FDA Status | Not approved | Not approved (Phase III completed) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.